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Lactobacilli are probiotic commensal bacteria and potent modulators of immunity. When 
present in the gut or supplemented as probiotics, they beneficially modulate ex vivo 
immune responsiveness. Further, factors derived from several lactobacilli strains act 
immune regulatory in vitro. In contrast, Staphylococcus aureus (S. aureus) is known to 
induce excessive T cell activation. In this study, we aimed to investigate S. aureus-induced 
activation of human mucosal-associated invariant T cells (MAIT cells), γδ T  cells, NK 
cells, as well as of conventional CD4+ and CD8+ T cells in vitro. Further, we investigated 
if lactobacilli-derived factors could modulate their activation. PBMC were cultured with 
S. aureus 161:2 cell-free supernatants (CFS), staphylococcal enterotoxin A or CD3/CD28-
beads alone, or in combination with Lactobacillus rhamnosus GG-CFS or Lactobacillus 
reuteri DSM 17938-CFS and activation of T and NK cells was evaluated. S. aureus-CFS 
induced IFN-γ and CD107a expression as well as proliferation. Costimulation with lacto-
bacilli-CFS dampened lymphocyte-activation in all cell types analyzed. Preincubation with 
lactobacilli-CFS was enough to reduce subsequent activation, and the absence of APC 
or APC-derived IL-10 did not prevent lactobacilli-mediated dampening. Finally, lactate 
selectively dampened activation of unconventional T cells and NK cells. In summary, we 
show that molecules present in the lactobacilli-CFS are able to directly dampen in vitro 
activation of conventional and unconventional T cells and of NK cells. This study provides 
novel insights on the immune-modulatory nature of probiotic lactobacilli and suggests a 
role for lactobacilli in the modulation of induced T and NK cell activation.
Keywords: cell-free supernatant, immune modulation, lactobacilli, nK cells, probiotic, T cells, Staphylococcus 
aureus, superantigens
inTrODUcTiOn
Lactobacilli are commensal, lactic acid-producing bacteria with proven beneficial effects when used 
as dietary supplements or when present in the early neonatal gut. Lactobacilli appear to protect 
against certain immune-mediated diseases (1, 2) and have been suggested to act as important immune 
modulators, especially during early life. Indeed, different lactobacilli strains can modulate stimulated 
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responses in  vitro (3, 4) and supplementation with  different 
strains of lactobacilli is associated with dampened ex vivo PBMC 
responsiveness (5). In contrast, Staphylococcus aureus (S. aureus) 
is a pathobiont and a common colonizer of the infant gut (1, 6). 
S. aureus is a potent immune activator as superantigenic staphy-
lococcal enterotoxins (SE) are able to engage large numbers of 
conventional T cells via MHC-mediated binding to the variable 
domain of the T cell receptor (TCR) β-chain (7) or α-chain 
(8). It thereby efficiently avoids immune clearance by inducing 
T cell exhaustion and anergy (9). Despite obvious effects on the 
lymphocyte compartment as a whole, the effect of S. aureus and 
its enterotoxins on unconventional T cells and NK cells has not 
been extensively studied (10).
We have previously shown that colonization with S. aureus in 
early life is associated with increased PBMC cytokine-secretion 
at the age of two, while co-colonization with lactobacilli results in 
dampened immune reactivity in vitro (11), findings that together 
further support the hypothesis that lactobacilli are involved in 
immune regulation in vivo. In addition, we reported that soluble 
factors derived from lactobacilli dampen S. aureus-induced 
activation of CD4+ T cells on a cellular level and also reduce the 
release of T cell-associated pro-inflammatory cytokines (12), 
showing that lactobacilli can exert immune dampening effects 
on selected compartments of the immune system.
Lactobacilli mediate their immune-modulatory effects 
through the induction of regulatory cytokines, such as IL-10 
(13, 14), induction of T regulatory cells (15–17), modulation of 
APC (18–20), promotion of epithelial function and development 
(21), and by inhibition of pro-inflammatory cytokines (22, 23). 
Extracted cell surface components of lactic acid bacteria induce a 
more pro-inflammatory cytokine profile, whereas cell-free super-
natants (CFS) are more prone to induce an anti-inflammatory 
response by PBMC (24). The induction of pro-inflammatory 
responses seen with whole lactobacilli in vitro might not appro-
priately reflect peripheral immune cell modulation in  vivo, as 
whole bacteria will most likely not enter the blood stream in 
large numbers. Instead, bacterial metabolites have been shown 
to cross the epithelial barrier, retain their bioactive properties, 
and affect peripheral immunity in  vitro and in  vivo (24–26). 
Secreted factors produced by lactobacilli have been extensively 
examined and factors, such as p40 and histamine, are discussed 
as potential effector molecules (27, 28). However, if, and by 
which mechanisms, lactobacilli-derived molecules are able to 
mediate immune-modulatory effects on lymphocytes, is largely 
unknown.
Here, we investigated S. aureus and enterotoxin-mediated 
 activation of T cells and NK cells, and how lactobacilli-derived 
factors dampen S. aureus-induced activation in vitro. We show 
that soluble factors, including enterotoxins, derived from S. aureus 
161:2 potently induce several effector functions in unconven-
tional T cells and NK cells, in addition to conventional T cells. 
Soluble factors derived from two common probiotic lactobacilli 
strains, Lactobacillus rhamnosus (L. rhamnosus) GG (LGG) and 
Lactobacillus reuteri DSM 17938 (L. reuteri), were able to directly 
dampen S. aureus-induced lymphocyte-activation in  vitro, 
without the involvement of APC or APC-derived IL-10. This 
in vitro study provides a possible link to the immune-modulatory 
capacity of lactobacilli in vivo and suggests that lactobacilli can 
modulate pathogen-induced immune activation.
MaTerials anD MeThODs
subjects, ethics statement, and isolation 
of Peripheral Blood Mononuclear cells
A total of 18 healthy, anonymous, adult volunteers (age 18–65, 
both genders) were included in this study, which was approved 
by the Regional Ethic’s Committee at the Karolinska Institute, 
Stockholm, Sweden [Dnr 04-106/1 and 2014/2052-32]. All study 
subjects gave their informed written consent. Venous blood 
was collected in heparinized vacutainer tubes (BD Biosciences 
Pharmingen) and diluted with RPMI-1640 supplemented with 
20  mM HEPES (HyClone Laboratories, Inc.). PBMC were 
isolated by Ficoll-Hypaque (GE Healthcare Bio-Sciences AB) 
gradient separation. The cells were washed and resuspended in 
freezing medium containing 40% RPMI-1640, 50% FCS (Life 
Technologies), and 10% DMSO, gradually frozen in a freezing 
container (Mr. Frosty, Nalgene Cryo 1°C; Nalge Co.) and stored 
in liquid nitrogen.
strains of Bacteria and generation of 
Bacterial cell-Free supernatants
L. rhamnosus GG (ATCC 53103; isolated from the probiotic prod-
uct Culturelle), L. reuteri (DSM 17938, a gift from Biogaia AB), 
and S. aureus 161:2 (carrying the genes for SE A and H) were the 
species used in this study. The S. aureus strain was a kind gift from 
Åsa Rosengren, The National Food Agency, Uppsala, Sweden, who 
screened the strain for toxin genes by using PCR. The lactobacilli 
were cultured in MRS broth (Oxoid) at 37°C for 20 h and S. aureus 
in BHI broth (Merck) at 37°C for 72 h still culture. The bacteria 
were pelleted by centrifugation at 3400 g, and the CFS were sterile 
filtered (0.2 μm) and frozen at −20°C until used. All bacterial 
supernatants were diluted 1:1 (50%) with HEPES to neutralize the 
pH. The final CFS concentration used for cell stimulations was 
2.5%, unless stated otherwise. To investigate heat stability, the 
LGG-CFS was heat-treated for 10 min by boiling at 100°C.
In Vitro stimulation of PBMc
PBMC were thawed and washed before being counted and 
viability assessed by Trypan blue staining. Cells were resus-
pended to a final concentration of 1 × 106 cells/ml in cell culture 
medium (RPMI-1640 supplemented with 20  mM HEPES), 
penicillin (100  U/ml), streptomycin (100  μg/ml), l-glutamine 
(2 mM) (all from HyClone Laboratories Inc.), and 10% FCS (Life 
Technologies). The cells were seeded in flat-bottomed 48-well 
plates (Costar) for 24 h at 37°C in 5% CO2 atmosphere with cell 
culture medium alone as negative control or with Dynabeads 
Human T-Activator CD3/CD28 (Life Technologies) at 2:1 
(cell:bead) ratio, 20  ng/ml of SEA (Sigma–Aldrich), or with S. 
aureus 161:2-CFS. As control, 50  ng/ml of PMA +  1 μg/ml of 
Ionomycin (IO) (both from Sigma–Aldrich) was used during the 
last 4 h of incubation. When indicated, LGG-CFS or L. reuteri-
CFS was added together with the abovementioned stimuli during 
the entire incubation. Brefeldin A (BD Biosciences) was present 
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during the last 4 h of incubation. For the preincubation experi-
ments, PBMC were incubated with LGG-CFS or L. reuteri-CFS 
for 6  h and extensively washed with complete medium before 
being stimulated for 15 h.
l(+)-lactate Measurement  
and In Vitro assay
The concentrations of L(+)-lactate in bacteria-CFS were 
quantified in four batches of CFS from each lactobacilli and in 
two batches of S. aureus-CFS using a colorimetric Lactate assay 
kit II (Sigma–Aldrich), according to the manufacturer’s instruc-
tions. In brief, samples were mixed with a reaction master mix 
and incubated for 30  min at room temperature after which 
absorbance was measured at 450  nm. Results were analyzed 
using SoftMax Pro 5.2 rev C (Molecular Devices Corp.). Neither 
the cell culture medium nor the bacterial growth medium 
interfered with the absorbance. To investigate the effect of 
l-lactate on S. aureus-mediated lymphocyte-activation, l-lactate 
(Sigma–Aldrich) was added to PBMC cultures at concentrations 
0.75, 3.25, 7.5, or 38 mM ( physiologically, levels in blood vary 
between 2 and 20 mM).
Functional assays
For measuring proliferation, PBMC were labeled at 37°C with 
5 μM CellTrace™ Violet (Molecular Probes, Life Technologies), 
stimulated as described above, and cultured in complete 
medium at a concentration of 1 × 106 cells/ml for 5 days. For 
assessing cytotoxic potential, PBMC were stimulated for 18 h 
in the presence of α-CD107a antibodies (clone: H4A39, BD 
Biosciences).
il-10 and il-12 neutralization
PBMC were seeded with an IL-10 neutralizing monoclonal anti-
body (clone: JES3-9D7, Biolegend) or matched isotype control 
(clone: RTK2071, Biolegend) at a concentration of 2.5  μg/ml 
for 2  h. PBMC were then stimulated and incubated overnight. 
Alternatively, PBMC were seeded with an IL-12 neutralizing 
monoclonal antibody (clone: MT3279H, Mabtech) or matched 
isotype control (clone: MPC-11, Biolegend) at 1 μg/ml for 5 h. 
PBMC were then stimulated, together with an additional dose of 
αIL-12/isotype control, for 24 h.
cD14+ Monocyte isolation and Depletion
The human CD14 positive selection kit (StemCell Technologies) 
was used to isolate or deplete CD14+ monocytes from PBMC 
according to the instructions of the manufacturer. CD14-depleted 
PBMC were cultured with 2.5% S. aureus-CFS in the presence or 
absence of LGG-CFS for 24 h with brefeldin A present during the 
last 4 h of incubation. Whole PBMC served as control. Isolated 
CD14+ monocytes were cultured at a concentration 0.5 ×  106/
ml with 2.5% L.  reuteri-CFS, 2.5% S. aureus-CFS, 100  ng/ml 
ultrapure LPS, or 10 μg/ml Pam3Cys (both Invivogen) for 14 h 
before culture supernatants were collected. Purity was assessed 
for all donors by staining with CD3 (clone: SK7) (Biolegend) and 
CD14 (clone: B159) (BD Biosciences). The mean percentage of 
CD14+ cells was 0.49 ± 0.28% in the monocyte-depleted PBMC 
and 97.4 ± 1.67% after purification.
elisa
Levels of IL-6, IL-10, IL-17A, and IFN-γ in cell culture superna-
tants were determined by using sandwich ELISA (MabTech AB) 
according to the instructions from the manufacturer. The optical 
density was determined using a microplate reader (Molecular 
Devices Corp.) set at 405  nm. Results were analyzed using 
SoftMax Pro 5.2 rev C (Molecular Devices Corp.).
Flow cytometry
After incubation, cells were harvested to V-shaped staining plates 
and washed in PBS. The cells were stained with the LIVE/DEAD 
Fixable Dead Cell Stain Kit-Aqua (Life Technologies) according 
to instructions from the manufacturer. Blocking of cell surface 
Fc receptors was done using 10% human serum in FACS wash 
buffer (PBS, 2 mM EDTA, and 0.1% BSA), and staining of cell 
surface markers was performed using the following antibodies: 
CD3 (clone: UCHT1, SK7), CD4 (clone: RPA-T4), CD8 (clone: 
SK1), CD25 (clone: M-A251), CD56 (clone: B159), CD127 
(clone: HIL-7R-M21), CD161 (clone: HP-3G10), Vα7.2 (clone: 
3C10) (BD Biosciences or Biolegend), and pan γδ TCR (clone: 
IMMU510) (Beckman Coulter). After surface staining, cells 
were washed with FACS wash buffer and fixed/permeabilized 
with the transcription factor buffer set (BD Biosciences) accord-
ing to the manufacturer’s instructions. Intracellular blocking 
was done using 10% human serum, and cells were then stained 
for intracellular IFN-γ (clone: B27) or FoxP3 (clone: 2590/C7) 
(BD Biosciences). Stained cells were washed, resuspended, 
and acquired using a FACSVerse instrument and the FACS 
Suite software (both BD Biosciences). Lymphocytes were gated 
based on forward and side scatter properties. After gating on 
live cells, NK cells were gated as CD3−CD56+, T helper cells 
as CD3+CD4+, and T cytotoxic cells as CD3+CD8+. γδ T cells 
were classified as CD3+γδ TCR+, and MAIT cells were gated 
as CD3+CD161+Vα7.2+. Regulatory T cells were identified as 
CD4+CD25+FoxP3+CD127low. Unstimulated cells or correspond-
ing isotype-matched antibodies were used as negative controls. 
Analyses were done with FlowJo Software (TreeStar).
statistics
GraphPad Prism software (GraphPad Software) was used for 
statistical analysis. For all analyses, the non-parametric, paired 
Wilcoxon matched pairs test was applied. Differences were con-
sidered significant if p < 0.05. The significance levels used were 
*p < 0.05, **p < 0.01, and ***p < 0.001.
resUlTs
S. aureus 161:2-induced iFn-γ 
expression in T and nK cells  
is Partly il-12-Dependent
We have previously shown that S. aureus 161:2 induce potent 
activation of TH-cells and Tregs (12, 29). Here, we investigated 
if CFS derived from S. aureus 161:2 could also activate innate 
T cells like γδ T cells and MAIT cells as well as NK cells in addi-
tion to CD4+ and CD8+ T cells (gating strategies for the identi-
fication of T and NK cell populations are displayed in Figure 1). 
FigUre 1 | gating strategy used to identify T cells and nK cells by flow cytometry. Lymphocytes were gated based on side scatter (SSC) and forward 
scatter (FSC) properties. Live cells (negatively stained for the Live/Dead-marker) were gated either as CD3−CD56+ cells (NK cells) or as CD3+CD56− cells, which 
were further divided as CD4+ T cells, CD8+ T cells, pan γδ TCR+ cells (γδ T cells), or CD161+Vα7.2+ cells (MAIT cells). For all figures, gating strategies are described 
in the section “Materials and Methods.”
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S. aureus-CFS readily induced IFN-γ expression in the γδ T cell-, 
MAIT cell-, and NK cell populations, in addition to the CD4+ 
and CD8+ T cell populations (Figures 2A,B). Enterotoxins pro-
duced by S. aureus are classically thought to polyclonally activate 
a large number of adaptive T cells. However, we could show that 
purified SEA also induces IFN-γ expression in unconventional 
T cells and NK cells (Figure  2A). Considering that IL-12 is 
involved in the differentiation on naive T cells into TH1-cells 
and stimulates the production of IFN-γ from T cells and NK 
cells (30), we further investigated whether IL-12 was involved 
in S. aureus- and SEA-mediated IFN-γ induction. Indeed, there 
was a reduction, but not complete abrogation, in the percentage 
of IFN-γ+ cells in all investigated populations when IL-12 was 
neutralized (Figure 3).
lactobacilli-cFs Dampens stimulated 
iFn-γ responses in cD4+ and cD8+ 
T cells, γδ T cells, MaiT cells, and 
nK cells
We previously observed that several species of lactobacilli can 
dampen S. aureus-induced IFN-γ expression by PBMC (12), and 
FigUre 2 | S. aureus 161:2 induces iFn-γ expression in T cells and nK cells. PBMC were stimulated as indicated and analyzed by flow cytometry. (a) The 
percentage of IFN-γ+ cells among the CD4+ (n = 12–17), CD8+ (n = 12–18), γδ TCR+ (n = 7–15), CD161+Vα7.2+ (n = 6–7), and CD3−CD56+ (n = 8–17) lymphocyte 
populations is shown. (B) Examples of IFN-γ stainings of the cell populations described in (a). Boxes cover data values between the 25th and 75th percentiles, with 
the central line as median and error bars showing minimal and maximal values.
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FigUre 3 | S. aureus and sea-induced iFn-γ responses are partly il-12-dependent. PBMC were cultured in the presence of an IL-12 neutralizing or isotype 
antibody, stimulated as indicated, and analyzed by flow cytometry. The relative percentage of IFN-γ+ cells among the CD4+ (n = 7), CD8+ (n = 7), γδ TCR+ (n = 7), 
CD161+Vα7.2+ (n = 4), and CD3−CD56+ (n = 7) lymphocyte populations is shown. The percentage of IFN-γ+ cells in isotype-treated PBMC stimulated with S. aureus 
or SEA is set to 1, and the percentage of IFN-γ+ cells in α-IL-12-treated cultures is relative to the isotype. Bars show medians with interquartile range.
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that children who are co-colonized by lactobacilli and S. aureus 
have a dampened cytokine response in vitro compared to children 
who are colonized with S. aureus in the absence of lactobacilli 
(11). We therefore investigated whether two different lactobacilli 
strains, LGG and L. reuteri DSM 17938, both commonly used 
as probiotics (31–33), could modulate S. aureus-induced IFN-γ 
responses by both conventional and unconventional T cells as 
well as NK cells. Both LGG-CFS and L. reuteri-CFS dampened 
the S. aureus-induced IFN-γ response in all cell types investigated 
(Figures  4A,B). Interestingly, lactobacilli-CFS was also able to 
reduce the percentage of IFN-γ expressing cells induced by SEA 
and CD3/CD28-beads (Figure 4A). Lactobacilli-CFS alone did not 
induce expression of IFN-γ (Figure S1 in Supplementary Material).
lactobacilli-cFs reduces S. aureus-
induced Proliferation and cytotoxic 
Potential
Based on these results, we further investigated the modulatory 
effect of LGG-CFS and L. reuteri-CFS on S. aureus-induced 
lymphocyte activation. S. aureus-CFS induced both notable 
proliferation of CD4+ and CD8+ T cells (Figures  5A,B) and 
cytotoxic potential in CD8+ T cells, γδ T cells, and NK cells, 
measured as expression of CD107a, which is exposed at the 
surface of cytotoxic cells during the release of granular con-
tents (Figure  6). In accordance with the IFN-γ expression, 
lactobacilli-CFS could dampen or tended to dampen both 
proliferation and degranulation induced by S. aureus-CFS 
(Figures 5A,B and 6).
lactobacilli-Mediated Dampening of iFn-γ 
responses is il-10-independent
To investigate whether lactobacilli-CFS was required to be present 
continuously in the cultures in order to dampen IFN-γ responses, 
we preincubated PBMC cultures with LGG-CFS or L. reuteri-
CFS, which was followed by extensive washing prior to stimula-
tion with S. aureus-CFS. Interestingly, preincubation dampened 
IFN-γ expression in all cell types (Figure 7A). As lactobacilli are 
known to induce the production of IL-10, an important immune 
FigUre 4 | lactobacilli-cFs dampens S. aureus, sea, and cD3/cD28-induced iFn-γ responses. PBMC were stimulated as indicated in combination with 
either LGG-CFS or L. reuteri-CFS and analyzed by flow cytometry. (a) The relative percentage of IFN-γ+ cells among the CD4+ (n = 6–14), CD8+ (n = 6–15), γδ TCR+ 
(n = 5–15), CD161+Vα7.2+ (n = 4–7), and CD3−CD56+ (n = 6–15) lymphocyte populations is shown. The percentage of IFN-γ+ cells in the presence of lactobacilli-
CFS is relative to the percentage of IFN-γ+ cells in the absence of lactobacilli-CFS, which is set to 1. (B) Examples of IFN-γ stainings of the cell populations 
described in (a). Bars show medians with interquartile range.
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FigUre 5 | S. aureus-induced proliferation of cD4+ and cD8+ T cells is modulated by lactobacilli-cFs. Proliferation was assessed with CellTrace™ Violet 
after 5 days of stimulation with S. aureus 161:2-CFS and/or lactobacilli-CFS and analyzed by flow cytometry. (a) The percentage of proliferating cells among the 
CD4+ (n = 7) and CD8+ (n = 7) T cell populations. (B) Representative stainings of proliferating CD4+ or CD8+ T cells are shown. Boxes cover data values between 
the 25th and 75th percentiles, with the central line as median and error bars showing minimal and maximal values.
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regulatory cytokine, we speculated that lactobacilli-induced 
monocyte-derived IL-10 was responsible for the reduction in 
IFN-γ. Lactobacilli-CFS induced IL-10 secretion in cultures of 
purified CD14+ monocytes (Figure 7B) and in PBMC cultures 
(Figure 7C). Neutralization of IL-10 tended to result in increased 
IFN-γ secretion from S. aureus-stimulated PBMC cultures but 
did not influence lactobacilli-mediated dampening (Figure 7D), 
indicating that the effect was IL-10 independent. Further, deple-
tion of monocytes from PBMC cultures did not seem to prevent 
dampening of S. aureus-induced intracellular IFN-γ expression 
(Figure 7E).
Expression of the transcription factor FoxP3 is a hallmark 
feature of T regulatory cells. L. reuteri-CFS neither altered the 
percentage of CD25+Foxp3+CD127low cells among the CD4 T cells 
nor affected the magnitude of FoxP3 expression (Figure  7F), 
indicating that T regulatory cells were not involved in lactobacilli-
mediated dampening.
lactate selectively inhibits the iFn-γ 
response of Unconventional T cells 
and nK cells
To further characterize the dampening effect, we heat-treated the 
lactobacilli-CFS. The heat-treated LGG and regular LGG seemed 
to similarly reduce IFN-γ expression (Figure 8), suggesting that 
the effect is mediated by a heat-stable component. Lactobacilli 
produce heat-stable lactic acid, which is known to modulate 
lymphocyte-activation through acidification. Considering that 
the CFS used in this study were pH-neutral and that lactobacilli 
metabolize glucose into lactate, we hypothesized that lactate 
FigUre 6 | S. aureus-induced cytotoxic potential in cD8+ T cells, 
γδ T cells, and nK cells is reduced by lactobacilli-cFs. PBMC were 
stimulated for 18 h in the presence of α-CD107a antibodies and the 
percentage CD107a+ cells among the CD8+ (n = 7), γδ TCR+ (n = 5), and 
CD3−CD56+ (n = 7) lymphocyte populations was analyzed by flow cytometry. 
Boxes cover data values between the 25th and 75th percentiles, with the 
central line as median and error bars showing minimal and maximal values.
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could be responsible for the observed immune modulation. First, 
we confirmed the presence of lactate in the CFS (Table 1). We 
then investigated whether commercial lactate at physiologically 
relevant concentrations could mimic the modulatory capacity 
of lactobacilli-CFS. Notably, lactate dampened the percentage 
of IFN-γ expressing MAIT cells, γδ T cells, and NK cells, after 
stimulation with S. aureus-CFS, in a dose-dependent manner 
(Figure 9A). Interestingly, CD4+ and CD8+ T cell IFN-γ expres-
sion was not affected (Figure 9B). Lactate at concentrations of 
7.5 mM or below did not affect cell viability.
DiscUssiOn
We previously demonstrated an inverse association between early 
life colonization with lactobacilli and S. aureus, and cytokine 
production in infancy (11). This was further evaluated by in vitro 
studies, where lactobacilli-CFS dampened S. aureus-induced 
IFN-γ and IL-17A responses, although the responding cell types 
were not identified (12). In this study, we show that unconven-
tional T cells and NK cells, in addition to conventional T cells, 
are strongly activated by S. aureus-CFS and SEA, and that CFS 
derived from lactobacilli is able to dampen in  vitro activation 
of these cell types. Our data suggest that molecules present in 
the lactobacilli-CFS act directly on lymphocytes to reduce the 
activation since a shorter pre-stimulation of PBMC was enough 
to reduce subsequent activation, and because the absence of APC 
or APC-derived IL-10 did not prevent lactobacilli-mediated 
dampening. Finally, we show that lactate is a possible modulator 
of unconventional T cell and NK cell activation.
It is well established that SE are superantigens that activate 
large numbers of T cells through cross-linking of the TCR vari-
able α or β-chains with MHC class II molecules (7–9). However, 
bovine CD4+ T cells recognize a limited number of additional 
S. aureus-antigens, implying that the mode of S. aureus-induced 
activation extends beyond enterotoxins (34). Despite the obvious 
impact on T cells, S. aureus-induced activation of T cells is under-
studied and mostly conducted in mice (9). Recently, we could 
show that S. aureus 161:2-CFS induced human CD4+FoxP3+ 
cells and promoted a diverse phenotype with the production of 
regulatory and pro-inflammatory cytokines (29), illustrating the 
complex interrelationship between S. aureus and the immune 
system. We now extend these findings and show that S. aureus 
161:2-CFS and SEA activate and induce IFN-γ expression in 
human γδ T cells, MAIT cells, and NK cells, in addition to CD4+ 
and CD8+ T cells. Further, S. aureus-CFS induced both prolifera-
tion and degranulation.
To the best of our knowledge, MAIT cell responsiveness 
toward SE has not yet been evaluated. In normal settings, MAIT 
cells respond to bacteria-derived organic compounds originating 
from the riboflavin biosynthetic pathway in an MR1 and APC-
dependent manner (35, 36). Like many bacteria, S. aureus uses 
the riboflavin pathway and promotes the activation of MAIT cells 
(37, 38). However, MAIT cells were not activated by CFS derived 
from the enterotoxin-negative S. aureus strain 139:3 (unpublished 
observation), indicating that enterotoxins are the main factors 
in S. aureus 161:2-mediated activation of the MAIT cells in our 
setting. Indeed, pure SEA induced activation of MAIT cells.
The activation of γδ T cells and NK cells involves antigen-
presenting or accessory cells. Monocyte-derived IL-12 is a key 
cytokine in S. aureus-mediated NK cell activation (39, 40). 
NK  cells also respond to SEA in an IL-12-dependent manner 
(41). Indeed, when neutralizing IL-12, the IFN-γ response toward 
both S. aureus-CFS and SEA was clearly reduced, in particular 
for the γδ T cells and NK cells, but also for the MAIT cells (not 
significant).
The main subpopulation of γδ T cells in peripheral blood 
primarily responds to bacterial species capable of producing 
the isoprenoid precursor (E)-4-hydroxy-3-methyl-but-2-enyl 
pyrophosphate (HMB-PP). This metabolite is not produced by 
S. aureus (38), and therefore it is interesting to note that γδ T cells 
respond to both S. aureus-CFS and SEA. Upon SEA inhalation, 
αβ T cell responses are crucial for subsequent activation of innate 
cells, including γδ T cells and NK cells, in mice (42). This could 
suggest that the activation of unconventional T cells and NK cells 
FigUre 7 | lactobacilli-mediated inhibition of iFn-γ responses is not dependent on monocyte-derived il-10. (a) The percentage of IFN-γ+ cells among 
the CD4+ (n = 9–14), CD8+ (n = 9–14), γδ TCR+ (n = 4–9), CD161+Vα7.2+ (n = 4), and CD3−CD56+ (n = 6–13) lymphocyte populations. Briefly, PBMC were 
preincubated with lactobacilli-CFS for 5 h and thereafter washed and stimulated with S. aureus-CFS. The percentage of IFN-γ+ cells in the presence of lactobacilli-
CFS is relative to the percentage of IFN-γ+ cells in the absence of lactobacilli-CFS, which is set to 1. (B) Secreted levels (picogram per milliliter) of IL-10 from 
stimulated CD14+ cell cultures measured by ELISA (n = 3). (c) Secreted levels of IL-6, IL-10, IFN-γ, and IL-17A in PBMC cultures (n = 3) measured by ELISA. ND, 
not detected. (D) The relative IFN-γ secretion in PBMC cultures stimulated in the presence or absence of an α-IL-10 antibody. Left: levels of IFN-γ secretion in 
PBMC cultures stimulated with S. aureus is set to 1, and the levels of IFN-γ secretion in α-IL-10-treated PBMC cultures stimulated with S. aureus-CFS are shown as 
relatives to 1. Right: levels of IFN-γ secretion in PBMC cultures stimulated with S. aureus in the absence of lactobacilli-CFS is set to 1, and the levels of IFN-γ 
secretion in α-IL-10-treated PBMC cultures stimulated with S. aureus-CFS in the presence of lactobacilli-CFS are shown as relatives to 1. (e) The percentage of 
IFN-γ+ cells among the CD4+ (n = 5), CD8+ (n = 4), γδ TCR+ (n = 5), CD161+Vα7.2+ (n = 3), and CD3−CD56+ (n = 5) lymphocyte populations in monocyte-depleted 
PBMC cultures after stimulation with S. aureus-CFS in the absence or presence of LGG-CFS. (F) The percentage of CD25+FoxP3+CD127low cells and the MFI of 
FoxP3 in CD4+ T cells after stimulation with L. reuteri-CFS. Bars show medians with interquartile range. Boxes cover data values between the 25th and 75th 
percentiles, with the central line as median and error bars showing minimal and maximal values.
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are secondary when stimulating PBMC with S. aureus-CFS or 
SEA. However, purified bovine γδ T cells are directly activated 
by SEA and SEB (43). Finally, SE have been shown to interact 
with additional receptors, including CD28, which confers 
co-stimulatory signals upon binding to CD80/CD86 on APC 
(44), indicating additional modes of enterotoxin-induced T cell 
activation.
Whole lactobacilli are described to induce both immune 
activation and regulation in a species-specific manner (17, 39, 
45–47). Also, live and heat-treated cells of the same lactobacilli 
strain may differently affect immune cells (48). In addition, the 
capacity to activate and modulate human blood APC was similar 
for LGG soluble factors and whole bacteria (49). However, we 
have previously shown that lactobacilli-CFS from several differ-
ent species all acted immune regulatory without activating the 
lymphocyte compartment (12). Here, we studied how CFS from 
two strains (LGG and L. reuteri DSM 17938) influenced activa-
tion of the T and NK cell compartments. Indeed, stimulation of 
PBMC with lactobacilli-CFS did not induce any T or NK cell 
activation, in terms of proliferation, degranulation, or IFN-γ pro-
duction. Instead, the percentage of IFN-γ+ cells was dampened 
by lactobacilli-CFS upon activation regardless of the stimulus 
used. Furthermore, CD4+ and CD8+ T cell proliferation, induced 
by S. aureus, was dampened by both LGG and L. reuteri. Whole 
lactobacilli and lactobacilli-CFS have been shown to suppress 
proliferation of human CD4+ and CD8+ T cells without altering 
T cell cytokine production. This was mediated by lactobacilli-
induced inhibition of the monocarboxylate transporter MCT-1 
(50), through which compounds can mediate changes in T cell 
growth without affecting cytokine expression (51). However, 
the prominent dampening of IFN-γ observed in the present 
study suggests other modes of regulation. Mouse CD4+ T cell 
proliferation was shown to be reduced by L. gasseri-RNA in a 
MyD88-dependent manner (52), and L. helveticus inhibits the 
proliferation of LPS-stimulated murine T cells through the reduc-
tion of phosphorylation of c-Jun N-terminal kinase (JNK), which 
halters the cell cycle at the G2/M phase and thereby prevents cell 
cycle progression (53).
The lactobacilli-CFS also hampered cytotoxic potential in 
CD8+ T cells, γδ T cells, and NK cells. To our knowledge, this is 
the first time lactobacilli have been shown to influence CD107a 
expression in cytotoxic lymphocytes.
To investigate whether dampening of lymphocyte activation 
required a continuous presence of lactobacilli-derived factors, 
we preincubated PBMC with the lactobacilli-CFS, followed by 
extensive washing before stimulation with S. aureus-CFS or SEA. 
Also, in this setup, both LGG-CFS and L. reuteri-CFS were able 
to suppress the IFN-γ response to the same extent as if continu-
ously present, showing that factors present in the lactobacilli-CFS 
alter the capacity of the cells to respond toward later microbial 
stimulation. Lactobacilli have been shown to induce suppressor 
of cytokine signaling (SOCS), a negative regulator of pro-inflam-
matory cytokines, in human primary macrophages (54) and in 
hepatocellular carcinoma cells, which were then desensitized 
to subsequent LPS-stimulation (55). If lactobacilli are able to 
induce SOCS-expression also in human T cells remains to be 
investigated.
FigUre 8 | The dampening capacity of lactobacilli-cFs is not 
affected by heat treatment. The relative percentage of IFN-γ+ cells among 
the CD4+, CD8+, γδ TCR+, and CD3−CD56+ lymphocytes populations 
(n = 3–4) after stimulation with S. aureus-CFS alone or in combination with 
regular or heat-treated (HT) LGG-CFS. The percentage of IFN-γ+ cells in the 
presence of LGG-CFS is relative to the percentage of IFN-γ+ cells in the 
absence of lactobacilli-CFS, which is set to 1. Bars show medians with 
interquartile range.
TaBle 1 | concentrations of l(+)-lactate (mM).
cFsa start of cell cultureb
L. rhamnosus GG (LGG) 154.8 ± 7.4 3.9
L. reuteri DSM 17938 93 ± 2.5 2.3
S. aureus 161:2 ND –
aConcentrations are shown as mean ± SEM and are adjusted for the background level 
of the lactobacilli growth medium.
bCalculated values after dilution of CFS at the start of cell culture.
ND: not detected.
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Several studies have attributed the immune-modulatory 
potential of lactobacilli to their induction of IL-10 production 
by immune cells (13, 14, 24). Niers et al. showed that lactobacilli 
inhibit PHA-induced type 2 cytokines, partially via IL-10 induc-
tion (56). However, the lactobacilli-mediated dampening of 
IFN-γ responses observed in this study was IL-10-independent. 
In fact, the capacity of several lactobacilli strains to induce IL-10 
in PBMC cultures varies to a high degree, yet all seem to have 
the ability to similarly dampen IFN-γ (our unpublished data). 
Further, strains of L. plantarum have been shown to ameliorate 
colitis also in IL-10-deficient mice (57, 58).
The sensing of, and signaling induced by, lactobacilli require 
further investigation. As reviewed by Yan and Polk, a LGG-derived 
protein, p40, has been attributed immune-modulatory functions, 
through the inhibition of epithelial cell apoptosis and inhibition 
of innate cytokine production (27). Heat treatment of LGG-CFS 
did not alter the capacity to dampen the IFN-γ response, implying 
that a heat-sensitive peptide/protein did not mediate dampening 
in our setting.
Lactobacilli species are known lactic acid-producing bacteria. 
Fisher et  al. reported that lactic acid inhibits antigen-specific 
CD8 T cell cytotoxicity and that this effect was connected to 
acidification (59), while others reported increased CTL acti-
vation in  vitro, but the opposite pattern in  vivo (60). Still, the 
dampening nature of the lactobacilli-CFS used in this study 
was not due to the acidification of the cell medium, as the 
CFS were pH-neutralized before added to cell cultures. We 
therefore investigated whether lactate, which does not acidify 
the cell medium, could be a possible factor contributing to the 
suppression of IFN-γ responses. Indeed, lactate was present in 
the lactobacilli-CFS at physiological concentrations in the cell 
cultures, and commercial lactate suppressed the IFN-γ response 
of MAIT cells, γδ T cells, and NK cells in a dose-dependent man-
ner. Intriguingly, tumor-derived lactate has been shown to inhibit 
NK cell activation and cytotoxicity (61). The responses exerted by 
activated T cells depend on alterations in the metabolic status, for 
example, in the glycolysis with lactic acid as an end product (62). 
This could, in part, explain why lactate acts differently on distinct 
FigUre 9 | l(+)-lactate dampens the S. aureus-induced iFn-γ response of γδ T cells, MaiT cells, and nK cells. PBMC were stimulated with  
S. aureus-CFS alone or in combination with lactate (LA 38, 7.5, 3.25, or 0.75 mM). (a) The relative percentage of IFN-γ+ cells among the CD161+Vα7.2+, γδ TCR+, 
and CD3−CD56+ lymphocyte populations (n = 6–8). (B) The relative percentage of IFN-γ+ cells among the CD4+ and CD8+ lymphocyte populations (n = 6). The 
percentage of IFN-γ+ cells in the presence of lactate are relative to the percentage of IFN-γ+ cells in cultures stimulated with S. aureus-CFS alone, which is set to 1. 
Bars show medians with interquartile range.
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